Vivos Inc. (RDGL)
USD 0.12
(-2.79%)
USD 0.12
(-2.79%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.79 Million USD | -10.94% |
| 2022 | - USD | -0.64% |
| 2021 | -2.5 Million USD | -273.67% |
| 2020 | -669.52 Thousand USD | 49.66% |
| 2019 | -18.74 Thousand USD | 46.2% |
| 2018 | -2.48 Million USD | 5.48% |
| 2017 | -2.51 Million USD | 41.01% |
| 2016 | -3.59 Million USD | -72.38% |
| 2015 | 8.89 Million USD | -32.37% |
| 2014 | -15.63 Million USD | 42.36% |
| 2013 | -1.66 Million USD | 37.43% |
| 2012 | -7 Million USD | -167.31% |
| 2011 | -1.79 Million USD | 40.9% |
| 2010 | -2.64 Million USD | -146.35% |
| 2009 | -2.58 Million USD | 68.6% |
| 2008 | -4.4 Million USD | -207.77% |
| 2007 | -1.47 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -577.13 Thousand USD | 100.0% |
| 2024 Q2 | -522.31 Thousand USD | 0.0% |
| 2023 Q2 | -914.4 Thousand USD | -268.24% |
| 2023 FY | - USD | -10.94% |
| 2023 Q3 | -687.63 Thousand USD | 24.8% |
| 2023 Q4 | -942.79 Thousand USD | -37.11% |
| 2023 Q1 | -248.31 Thousand USD | 64.81% |
| 2022 Q1 | -747.49 Thousand USD | -242.2% |
| 2022 FY | - USD | -0.64% |
| 2022 Q4 | -705.65 Thousand USD | -154.69% |
| 2022 Q3 | -277.06 Thousand USD | 64.82% |
| 2022 Q2 | -787.53 Thousand USD | -5.36% |
| 2021 FY | - USD | -273.67% |
| 2021 Q1 | -235.09 Thousand USD | 20.38% |
| 2021 Q2 | -1.85 Million USD | -688.5% |
| 2021 Q3 | -194.58 Thousand USD | 89.5% |
| 2021 Q4 | -218.44 Thousand USD | -12.26% |
| 2020 Q2 | -125.45 Thousand USD | -4.22% |
| 2020 Q4 | -295.25 Thousand USD | -129.88% |
| 2020 Q1 | -120.37 Thousand USD | 62.91% |
| 2020 FY | - USD | 49.66% |
| 2020 Q3 | -128.44 Thousand USD | -2.38% |
| 2019 FY | - USD | 46.2% |
| 2019 Q3 | -607.2 Thousand USD | -250.95% |
| 2019 Q4 | -324.55 Thousand USD | 46.55% |
| 2019 Q1 | -225.2 Thousand USD | 86.94% |
| 2019 Q2 | -173.01 Thousand USD | 23.17% |
| 2018 Q2 | -341.9 Thousand USD | -27.05% |
| 2018 Q3 | -136.9 Thousand USD | 59.96% |
| 2018 FY | - USD | 5.48% |
| 2018 Q4 | -1.72 Million USD | -1159.36% |
| 2018 Q1 | -269.11 Thousand USD | 59.91% |
| 2017 Q3 | -961.79 Thousand USD | -55.52% |
| 2017 FY | - USD | 41.01% |
| 2017 Q4 | -671.22 Thousand USD | 30.21% |
| 2017 Q2 | -618.43 Thousand USD | -69.91% |
| 2017 Q1 | -363.97 Thousand USD | -375.61% |
| 2016 Q2 | -3.21 Million USD | -372.01% |
| 2016 FY | - USD | -72.38% |
| 2016 Q4 | 132.06 Thousand USD | 119.84% |
| 2016 Q3 | -665.67 Thousand USD | 79.31% |
| 2016 Q1 | -681.79 Thousand USD | 58.0% |
| 2015 Q3 | -292.87 Thousand USD | 11.18% |
| 2015 FY | - USD | -32.37% |
| 2015 Q2 | -329.73 Thousand USD | -1.1% |
| 2015 Q1 | -326.14 Thousand USD | 14.38% |
| 2015 Q4 | -1.62 Million USD | -454.23% |
| 2014 Q1 | -542.69 Thousand USD | -32.8% |
| 2014 FY | - USD | 42.36% |
| 2014 Q2 | -529.08 Thousand USD | 2.51% |
| 2014 Q4 | -380.92 Thousand USD | 22.31% |
| 2014 Q3 | -490.32 Thousand USD | 7.33% |
| 2013 Q2 | -1.08 Million USD | 21.07% |
| 2013 FY | - USD | 37.43% |
| 2013 Q1 | -1.37 Million USD | 3.73% |
| 2013 Q4 | -408.66 Thousand USD | 15.84% |
| 2013 Q3 | -485.57 Thousand USD | 55.14% |
| 2012 Q1 | -916.82 Thousand USD | -49.88% |
| 2012 FY | - USD | -167.31% |
| 2012 Q4 | -1.42 Million USD | 34.6% |
| 2012 Q3 | -2.17 Million USD | -150.87% |
| 2012 Q2 | -868.19 Thousand USD | 5.3% |
| 2011 Q1 | -580.72 Thousand USD | 58.09% |
| 2011 Q2 | -435.04 Thousand USD | 25.09% |
| 2011 Q3 | -387.99 Thousand USD | 10.82% |
| 2011 Q4 | -611.71 Thousand USD | -57.66% |
| 2011 FY | - USD | 40.9% |
| 2010 Q1 | -904.71 Thousand USD | -744.73% |
| 2010 FY | - USD | -146.35% |
| 2010 Q3 | -824.77 Thousand USD | -179.61% |
| 2010 Q4 | -1.38 Million USD | -68.01% |
| 2010 Q2 | -294.97 Thousand USD | 67.4% |
| 2009 FY | - USD | 68.6% |
| 2009 Q4 | 140.32 Thousand USD | 121.47% |
| 2009 Q3 | -653.72 Thousand USD | -48.63% |
| 2009 Q2 | -439.84 Thousand USD | -2.05% |
| 2009 Q1 | -431.01 Thousand USD | 76.57% |
| 2008 Q1 | -1.13 Million USD | 0.0% |
| 2008 Q4 | -1.83 Million USD | -223.96% |
| 2008 Q2 | -1.36 Million USD | -20.23% |
| 2008 Q3 | -567.95 Thousand USD | 58.26% |
| 2008 FY | - USD | -207.77% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -918.319% |
| IR-Med Inc. | -4.89 Million USD | 42.904% |
| Polarean Imaging plc | -11.19 Million USD | 75.05% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 712.451% |
| Avitar, Inc. | -1.66 Million USD | -67.475% |
| AVITA Medical, Inc. | -39.56 Million USD | 92.941% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -139.961% |
| Össur hf. | 137.38 Million USD | 102.033% |
| Zecotek Photonics Inc. | -3.44 Million USD | 18.856% |
| QHSLab, Inc. | -91.29 Thousand USD | -2959.54% |
| Wellstar International, Inc. | -1.35 Million USD | -105.906% |
| Össur hf. | 137.38 Million USD | 102.033% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 128.577% |
| Escalon Medical Corp. | -58.46 Thousand USD | -4677.794% |
| Aurora Spine Corporation | -454.37 Thousand USD | -514.719% |
| BrainsWay Ltd. | -2.31 Million USD | -20.863% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 70.22% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 150.586% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.196% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1312.885% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -67.399% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -637.161% |
| Nanomix Corporation | -8.13 Million USD | 65.685% |
| Theraclion SA | -2.05 Million USD | -36.199% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -295.053% |
| Positron Corporation | -1.45 Million USD | -92.345% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -62.214% |
| Lombard Medical, Inc. | -28.06 Million USD | 90.049% |
| ALR Technologies Inc. | -6.4 Million USD | 56.359% |
| Stratec SE | 39.91 Million USD | 106.998% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 2867.053% |
| Heart Tronics, Inc. | -14.85 Million USD | 81.2% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -2261.889% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 78.962% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 69.48% |
| VMS Rehab Systems, Inc. | -68.55 USD | -4074511.233% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 10.648% |
| Ingen Technologies, Inc. | -8639.00 USD | -32231.821% |
| Odyssey Group International, Inc. | -2.13 Million USD | -30.638% |
| United American Healthcare Corporation | -59 Thousand USD | -4634.146% |
| ECGI Holdings, Inc. | -2.99 Million USD | 6.597% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -343.932% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -443.387% |
| Urologix, Inc. | -6.34 Million USD | 55.972% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -125.37% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -264.656% |
| SS Innovations International, Inc. | -20.37 Million USD | 86.292% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -1153.555% |
| Smith & Nephew plc | 1 Billion USD | 100.279% |
| NIOX Group Plc | 11.07 Million USD | 125.22% |
| Fuse Medical, Inc. | 1.83 Million USD | 252.189% |
| Broncus Holding Corporation | -25.19 Million USD | 88.916% |
| Brain Scientific Inc. | -7.93 Million USD | 64.794% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 70.257% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -15080.141% |